Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Assets Average (2016 - 2025)

Historic Assets Average for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $6.8 million.

  • Palisade Bio's Assets Average fell 3857.79% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 3857.79%. This contributed to the annual value of $12.5 million for FY2024, which is 1637.77% down from last year.
  • Per Palisade Bio's latest filing, its Assets Average stood at $6.8 million for Q3 2025, which was down 3857.79% from $7.4 million recorded in Q2 2025.
  • Over the past 5 years, Palisade Bio's Assets Average peaked at $17.7 million during Q3 2023, and registered a low of $6.0 million during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $12.2 million (2022), whereas its average is $12.1 million.
  • As far as peak fluctuations go, Palisade Bio's Assets Average soared by 10767.52% in 2023, and later tumbled by 4178.98% in 2025.
  • Over the past 5 years, Palisade Bio's Assets Average (Quarter) stood at $15.6 million in 2021, then grew by 2.58% to $16.0 million in 2022, then decreased by 2.84% to $15.6 million in 2023, then tumbled by 35.04% to $10.1 million in 2024, then tumbled by 32.53% to $6.8 million in 2025.
  • Its Assets Average was $6.8 million in Q3 2025, compared to $7.4 million in Q2 2025 and $9.5 million in Q1 2025.